Additional file 10 of Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practice

Additional file 10: Figure S7. Forest plots showing overall survival benefits of METscore-Low over METscore-High per PD-L1 status in (A) docetaxel and (B) atezolizumab arms in OAK. Abbreviations: HR, hazard ratio; CI, confidence interval; PD-L1, programmed death-ligand 1.